r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

OI

Opaleye Management Inc.

Insider · 10% owner · SLGL

Opaleye Management Inc. files insider transactions with the SEC as a 10% owner of Sol-Gel Technologies (SLGL). We hold 80 disclosed purchases and sales filed since 20 May 2015, 29 of them in the last 90 days.

  • Files forSLGL
  • Disclosed buys and sells80 in all, 29 in the last 90 days
  • Last disclosure3 September 2026

Positions held

16 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 20 November 2025 — 2 September 202610% owner · Sol-Gel Technologies (SLGL)52 Form 4 lines · source: SEC Form 4
  • Filed 14 August 2026 — 14 August 202610% owner · Grace Therapeutics (GRCE)1 Form 4 line · source: SEC Form 4
  • Filed 20 February 2026 — 3 August 202610% owner · Alpha Cognition (ACOG)73 Form 4 lines · source: SEC Form 4
  • Filed 16 October 2020 — 14 July 202610% owner · Eton Pharmaceuticals (ETON)59 Form 4 lines · source: SEC Form 4
  • Filed 29 April 2025 — 1 May 202610% owner · SANUWAVE Health (SNWV)14 Form 4 lines · source: SEC Form 4
  • Filed 20 May 2020 — 4 March 202610% owner · Harrow (HROW)83 Form 4 lines · source: SEC Form 4
  • Filed 18 September 2024 — 1 December 202510% owner · Codexis (CDXS)71 Form 4 lines · source: SEC Form 4
  • Filed 30 October 2024 — 1 November 202410% owner · SANUWAVE Health (SNWVD)5 Form 4 lines · source: SEC Form 4
  • Filed 30 September 2020 — 12 September 202410% owner · Protara Therapeutics (TARA)71 Form 4 lines · source: SEC Form 4
  • Filed 27 August 2020 — 10 November 202310% owner · Tracon Pharmaceuticals (TCON)87 Form 4 lines · source: SEC Form 4
  • Filed 10 June 2022 — 3 November 202210% owner · TELA Bio (TELA)32 Form 4 lines · source: SEC Form 4
  • Filed 10 June 2022 — 1 July 202210% owner · TELA Bio ("""TELA""")6 Form 4 lines · source: SEC Form 4
  • Filed 22 December 2020 — 16 March 202210% owner · Tracon Pharmaceuticals ("""TCON""")2 Form 4 lines · source: SEC Form 4
  • Filed 24 September 2020 — 24 September 202010% owner · Protara Therapeutics ("""TARA""")2 Form 4 lines · source: SEC Form 4
  • Filed 30 December 2019 — 2 January 202010% owner · Ocular Therapeutix (OCUL)3 Form 4 lines · source: SEC Form 4
  • Filed 19 May 2015 — 11 March 201610% owner · Imprimis Pharmaceuticals (IMMY)5 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.